Improved guidelines will optimize efficacy and minimize adverse effects of biosimilar drugs

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 8, August 2008 , pp. 24-26(3)

Publisher: Adis International

Keywords: Biotechnology; Biotherapies; Generic substitution; Legislation; Pharmaceutical industry; Pharmaceutical risk management; Regulatory process; Research and development

Document Type: Research article

Publication date: 2008-08-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Adis International Limited,

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers